USC Clinical Trials Partner Sites - University of the Sunshine Coast, Queensland, Australia

Accessibility links

USC Clinical Trials Partner Sites

Coast Joint Care - Rheumatology Research Unit

Giant Cell Arteritis
Do you have a Diagnosis of Giant Cell Arteritis?

USC A/Professor David Nicholls and the Rheumatology Research Unit are researching whether a drug called sarilumab is safe and effective in treating Giant Cell Arteritis (GCA). As part of this trial, we are also investigating if the duration of corticosteroids intake (current standard treatment for GCA) can be reduced when sarilumab is co-administered, in order to reduce their side-effects.

We are currently recruiting study participants who:

  • Are adults over 50 years of age
  • Have a diagnosis of Giant Cell Arteritis
  • Are newly diagnosed with GCA or have persisting symptoms despite current medications

Participants will need to attend 14 clinic visits over a 76 Week period.

To see if you are eligible please call the Rheumatology Research Unit on 07 5443 1033.

Full title: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis. Protocol EFC15068

Polymyalgia Rheumatica
Do you have a Diagnosis of Polymyalgia Rheumatica?

USC A/Professor David Nicholls and the Rheumatology Research Unit are researching whether a drug called sarilumab is safe and effective in treating Polymyalgia Rheumatica. The current primary treatment is corticosteroids which often results in side-effects when taken long-term. As part of this trial, we are also investigating if the duration of corticosteroid intake can be reduced when sarilumab is co-administered.

We are currently recruiting study participants who:

  • Have a confirmed diagnosis of Polymyalgia Rheumatica
  • Age 50 or over at the time of diagnosis
  • Are newly diagnosed with PMR or have persisting symptoms despite current medications

Participants will need to attend 13 clinic visits over a 58 Week period.

To see if you are eligible please call the Rheumatology Research Unit on 07 5443 1033.

Full title: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with polymyalgia rheumatica. Protocol EFC15160

Coastal Digestive Health

Crohn's Disease
Do you have Crohn's Disease?

This is a clinical trial of an investigational product for induction and maintenance of remission of moderately to severely active Crohn’s Disease, to be conducted by the University of the Sunshine Coast (QLD) in partnership with Coastal Digestive Health.

To see if you are eligible please call USC Clinical Trials Sippy Downs on 07 5456 3797

Full title: Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn’s Disease

Coast Joint Care, Rheumatology Research Unit

9-10 Denna St
Maroochydore QLD 4558

07 5443 1033

Coastal Digestive Health

5 Emporio Pl 
Maroochydore QLD 4558